Related Articles

News
STAT+: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease
November 15, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease
“The idea of reversing disease is not part of the lexicon of physicians, because the idea of reversing disease is tantamount to reversing time.” […]

News
STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
July 25, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
Elon Musk’s Neuralink has been the buzz of Silicon Valley and beyond. But it’s hardly the only company developing “brain-computer interfaces.” […]

News
This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women
June 30, 2022
San Francisco Biotechnology Network News
News
Comments Off on This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women
Ensuring that trial participants come from diverse backgrounds will mean that the next generation of screening — personalized screening — might have a shot at helping people regardless of their… […]